List of largest biomedical companies by revenue

Last updated

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by their revenue in the respective financial year.

Contents

It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.

Ranking by revenue

The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the preceding year. Red cells indicate those years when there has been a decrease.

Largest biotechnology and pharmaceutical companies ranked by revenue in billion USD.
RankChgCompanyCountryTraded on2024202320222021202020192018201720162015
1Steady2.svg Johnson & Johnson Flag of the United States.svg  USA NYSE :  JNJ 88.82 [1] 85.16 [2] 79.99 [2] 93.78 [3] 82.59 [3] 82.06 [4] 81.60 [5] 76.50 [6] 71.89 [7] 70.10 [8]
2Steady2.svg Sinopharm Flag of the People's Republic of China.svg  CHN SEHK :  1099 84.06 [9] 80.19 [10] 75.68 [10] 71.75 [11] 60.18 [12] 48.75 [13] 43.63 [14] 36.56 [15] 32.36 [16]
3Steady2.svg Roche Flag of Switzerland (Pantone).svg  SUI SIX :  ROG 66.42 [17] 68.48 [18] 69.77 [19] 67.83 [20] 62.99 [20] 63.85 [21] 56.86 [22] 57.37 [23] 50.11 [24] 47.70 [25]
4Steady2.svg Merck & Co. Flag of the United States.svg  USA NYSE :  MRK 64.17 [26] 60.12 [27] 59.28 [28] 48.70 [29] 41.52 [29] 46.84 [30] 42.30 [31] 40.10 [32] 39.80 [33] 39.50 [34]
5Steady2.svg Pfizer Flag of the United States.svg  USA NYSE :  PFE 63.63 [35] 59.55 [35] 100.33 [36] 81.29 [37] 41.91 [38] 41.17 [38] 40.83 [38] 52.54 [39] 52.82 [40] 48.85 [41]
6Steady2.svg AbbVie Flag of the United States.svg  USA NYSE :  ABBV 56.33 [42] 54.32 [43] 58.05 [44] 56.20 [45] 45.80 [45] 33.27 [46] 32.75 [47] 28.22 [48] 25.56 [49] 22.82 [50]
7Steady2.svg Bayer Flag of Germany.svg  GER FWB :  BAYN 51.72 [51] 53.88 [52] 49.46 [53] 47.40 [54] 48.02 [55] 45.06 [56] 37.94 [57] 25.27 [58] 24.09 [59]
8Increase2.svg 2 Novartis Flag of Switzerland (Pantone).svg  SUI NYSE :  NVS 50.32 [60] 45.44 [61] 50.55 [62] 51.63 [63] 48.66 [63] 47.45 [64] 44.75 [65] 49.11 [66] 48.52 [67] 49.41 [68]
9Decrease2.svg 1 Sanofi Flag of France.svg  FRA NYSE :  SNY 42.68 [69] 46.84 [70] 46.86 [71] 43.24 [72] 41.27 [73] 39.28 [74] 39.07 [75] 42.91 [76] 36.57 [77] 36.73 [78]
10Decrease2.svg 1 AstraZeneca Flag of the United Kingdom.svg  GBR
Flag of Sweden.svg  SWE 		LSE :  AZN 45.81 [79] 44.35 [80] 37.42 [81] 26.62 [82] 24.38 [83] 22.09 [84] 22.47 [85] 23.00 [86] 24.71 [87]
11Steady2.svg Bristol Myers Squibb Flag of the United States.svg  USA Nasdaq :  BMY 45.01 [88] 46.16 [89] 46.39 [90] 42.52 [90] 26.15 [91] 22.56 [92] 20.80 [93] 19.43 [94] 16.56 [95]
12Steady2.svg Abbott Laboratories Flag of the United States.svg  USA Nasdaq :  ABT 41.95 [96] 40.11 [97] 43.65 [98] 43.08 [99] 34.61 [100] 31.90 [101] 30.60 [102] 27.39 [103] 20.85 [104] 20.41 [105]
13Increase2.svg 3 Novo Nordisk Flag of Denmark.svg  DEN NYSE :  NVO 40.52 [106] 33.83 [107] 25.46 [108] 21.66 [109] 19.52 [109] 18.30 [110] 6.99 [111] 18.77 [112] 16.61 [113] 16.06 [114]
14Decrease2.svg 1 GlaxoSmithKline Flag of the United Kingdom.svg  GBR LSE :  GSK 39.28 [115] 38.63 [116] 36.14 [117] 46.91 [118] 46.17 [119] 43.92 [120] 43.14 [121] 42.05 [122] 34.79 [123] 29.84 [124]
15Decrease2.svg 1 Shanghai Pharmaceuticals Flag of the People's Republic of China.svg  CHN SSE : 601607 36.68 [125] 32.33 [126] 31.82 [127] 29.29 [127] 27.50 [127] 23.45 [127] 19.28 [127] 17.80 [128] 15.55 [128]
16Decrease2.svg 1 Eli Lilly & Co Flag of the United States.svg  USA NYSE :  LLY 34.12 [129] 28.54 [130] 28.32 [131] 24.54 [132] 22.32 [133] 21.49 [134] 22.90 [135] 21.22 [136] 20.00 [137]
17Steady2.svg Takeda Pharmaceutical Flag of Japan.svg  JPN TYO : 4502 30.24 [138] 30.34 [139] 29.31 [140] 27.76 [141] 31.17 [142] 19.10 [143] 16.70 [144] 15.96 [145] 14.93
18Steady2.svg Amgen Flag of the United States.svg  USA Nasdaq :  AMGN 33.42 [146] 28.19 [147] 26.32 [148] 25.98 [149] 25.42 [150] 23.40 [151] 23.70 [152] 22.80 [153] 22.99 [154] 21.66 [155]
19Steady2.svg Boehringer Ingelheim Flag of Germany.svg  GER Private27.70 [156] 25.90 [157] 22.50 [158] 22.40 [159] 21.75 [160] 21.67 [161] 17.54 [162] 16.41 [162] 17.70 [162]
20Steady2.svg Gilead Sciences Flag of the United States.svg  USA Nasdaq :  GILD 27.12 [163] 27.28 [164] 27.31 [164] 24.69 [165] 22.45 [166] 22.13 [167] 25.70 [168] 30.39 [168] 32.15 [168]
21Increase2.svg 1 Siemens Healthineers Flag of Germany.svg  GER FWB :  SHL 23.32 [169] 23.09 [170] 20.61 [171] 16.56 [171] 16.62 [172] 15.37 [173] 16.56 [174] 14.25 [174] 14.06 [174]
22Decrease2.svg 1 Merck Group Flag of Germany.svg  GER ETR: MRK 22.79 [175] 23.64 [176] 21.40 [177] 20.08 [178] 18.25 [179] 16.48 [180] 18.70 [181] 16.62 [182] 14.25 [183]
23Steady2.svg Jointown Pharmaceutical Flag of the People's Republic of China.svg  CHN SSE : 600998 21.15 [184] 19.81 [185] 18.04 [186] 16.34 [187] 14.67 [188] 12.85 [189] 10.90 [190] 9.07 [191] 7.31 [192]
24Steady2.svg GE Healthcare Flag of the United States.svg  USA Nasdaq :  GEHC 19.55 [193] 18.34 [194] 17.73 [195] 18.01 [196] 19.94 [197] 19.78 [197] 19.02 [197] 18.21 [197] 17.64 [197]
25Steady2.svg Teva Pharmaceuticals Flag of Israel.svg  ISR Nasdaq :  TEVA 16.54 [198] 15.85 [199] 14.93 [200] 15.88 [201] 16.66 [202] 16.89 [203] 18.90 [204] 22.40 [205] 21.90 [206] 20.00 [207]
26Steady2.svg Kenvue Flag of the United States.svg  USA NYSE :  KVUE 15.44 [208] 14.95 [208]
27Steady2.svg Viatris Flag of the United States.svg  USA Nasdaq :  VTRS 15.43 [209] 16.22 [210] 17.81 [210] 11.95 [211]
28Steady2.svg Baxter International Flag of the United States.svg  USA NYSE :  BAX 14.81 [212] 15.11 [213] 12.78 [214] 11.63 [215] 11.36 [215] 11.13 [216] 10.56 [216] 10.16 [217] 9.97 [218]
29Steady2.svg Haleon Flag of the United Kingdom.svg  GBR LSE :  HLN 14.29 [219] 13.14 [220] 11.77 [221]
30Steady2.svg Otsuka Holdings Flag of Japan.svg  JPN TYO : 4578 14.23 [222] 13.05 [223] 11.65 [224] 11.06 [224] 10.85 [224] 10.04 [224] 9.64 [224] 9.29 [224] 11.10 [224]
31Steady2.svg Regeneron Pharmaceuticals Flag of the United States.svg  USA Nasdaq :  REGN 14.20 [225] 13.12 [226] 12.17 [227] 16.07 [228] 8.50 [228] 7.86 [229] 6.71 [229] 5.87 [229] 4.86 [230] 4.10 [231]
32Steady2.svg Astellas Pharma Flag of Japan.svg  JPN TYO : 4503 10.14 [232] 10.87 [233] 10.08 [234] 10.85 [235] 11.29 [235] 12.27 [236] 12.0712.6311.48

See also

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is an American trade group representing companies in the pharmaceutical industry. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, D.C.

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Judy Lewent</span>

Judith Carol Lewent is a business executive who served as chief financial officer of Merck & Co. from 1990 until her retirement from the company in 2007. Since her retirement from Merck, she has continued to serve on multiple corporate boards, including the boards of GlaxoSmithKline, Thermo Fisher Scientific and Motorola Solutions. She also served on the board of Purdue Pharma until her departure from the company in 2014.

<span class="mw-page-title-main">Elias Zerhouni</span> Algerian-American radiologist

Elias Zerhouni is an Algerian-born American scientist, radiologist, biomedical engineer, entrepreneur, and pharmaceutical industry executive, known for having been the 15th Director of the National Institutes of Health.

<span class="mw-page-title-main">Genome Valley</span> Life Sciences in Telangana, India

Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 kms from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).

<span class="mw-page-title-main">American Society of Hematology</span> Organization

The American Society of Hematology (ASH) is a professional organization representing hematologists, founded in 1958. Its annual meeting is held in December of every year and has attracted more than 30,000 attendees. The society publishes the medical journal Blood, the most cited peer-reviewed publication in the field, and Blood Advances, an online, peer-reviewed open-access journal.

The National Health Council (NHC) is a nonprofit association of health organizations.

<span class="mw-page-title-main">AIM at Melanoma Foundation</span> Nonprofit melanoma treatment research organization

The AIM at Melanoma Foundation(AIM) is a nonprofit organization focused on melanoma research.

The Reagan-Udall Foundation for the Food and Drug Administration is a private nonprofit (501c3) organization, created to support the mission of the U.S. Food and Drug Administration (FDA) to help equip FDA staff with the highest caliber, regulatory science and technology in order to enhance the safety and effectiveness of FDA regulated products. Although it was mandated by Congress in the Food and Drug Administration Amendments Act of 2007 to help support and promote FDA's regulatory science priorities, it is independent of the agency, with its own Board of Directors, staff and research agenda. The Reagan-Udall Foundation creates public–private partnerships to advance research in regulatory science, enhance medical decision making, and promote innovation. It also advances regulatory science through fellowships and other training programs, both for private scientists and for FDA staff.

The pharmaceutical industry in Pakistan was estimated to be worth Rs. 748 billion (US$2.6 billion) in 2023, representing about 1% of the country's GDP. The industry is largely import-dependent, with more than 90% of raw material being imported and only 12% of active pharmaceutical ingredients locally produced. Pakistani pharmaceutical companies are engaged in importing raw materials, compounding active pharmaceutical ingredients with excipients, coating of pills, and fill-finish activities. The industry is regulated by the Drug Regulatory Authority of Pakistan, which oversees drug approvals and pricing.

Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety.

Evolocumab, sold under the brand name Repatha, is a monoclonal antibody that is an immunotherapy medication for the treatment of hyperlipidemia.

<span class="mw-page-title-main">Sanofi–GSK COVID-19 vaccine</span> Protein subunit vaccine against COVID-19

The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK.

<span class="mw-page-title-main">Pharmaceutical Advertising Advisory Board</span> Canadian not-for-profit organization

The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario. Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals. It is financed on a fee-for-service basis.

BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. ↑ "Johnson & Johnson Reports Q4 and Full-Year 2024 Results" (PDF).
  2. 1 2 "Johnson & Johnson Reports Q4 and Full-Year 2023 Results".
  3. 1 2 Johnson & Johnson Reports Q4 and Full-Year 2021 Results (Report). Johnson & Johnson. 25 January 2022.
  4. ↑ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results". BioSpace. Retrieved 24 December 2022.
  5. ↑ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  6. ↑ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  7. ↑ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  8. ↑ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  9. ↑ "Annual Results Announcement for the year ended 31 December 2023" (PDF).
  10. 1 2 "Annual Results Announcement for the year ended 31 December 2022" (PDF).
  11. ↑ All For Health Health For All: Annual Report 2020 (PDF) (Report). Sinopharm Group Co. Ltd. 2020.
  12. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  13. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  14. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  15. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  16. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  17. ↑ "Roche 2024 results" (PDF).
  18. ↑ "Roche Finance Report 2023" (PDF).
  19. ↑ "Roche Finance Report 2022" (PDF).
  20. 1 2 "[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021". Roche.
  21. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
  22. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
  23. ↑ "Roche reports good results in 2017". www.roche.com.
  24. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  25. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  26. ↑ "Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results".
  27. ↑ "Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results" (PDF).
  28. ↑ "Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results".
  29. 1 2 "Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results".
  30. ↑ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  31. ↑ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  32. ↑ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC .
  33. ↑ Merck & Co., Inc US Securities and Exchange Office
  34. ↑ Merck & Co., Inc US Securities and Exchange Office
  35. 1 2 "Pfizer Reports Strong Full-Year 2024 Results" (PDF).
  36. ↑ "Pfizer Reports Record Full-Year 2022 Results" (PDF).
  37. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2021 Results (PDF) (Report). Pfizer. 2021.
  38. 1 2 3 Annual report Pfizer
  39. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2017 Results Provides 2018 Financial Guidance (PDF) (Report). Pfizer. 30 January 2018.
  40. ↑ Appendix A: 2016 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2016.
  41. ↑ 2015 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2015.
  42. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results".
  43. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results".
  44. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results".
  45. 1 2 "AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results". North Chicago, Ill.: Abbvie. 2 February 2022. Retrieved 2022-09-26.
  46. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  47. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  48. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  49. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  50. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  51. ↑ "Bayer Annual Report 2023" (PDF).
  52. ↑ "Bayer Annual Report 2022" (PDF).
  53. ↑ Bayer Annual Report 2021 (PDF) (Report). Bayer. 2021.
  54. ↑ "Bayer Annual report 2020" (PDF).
  55. ↑ "Bayer Annual Report 2019" (PDF).
  56. ↑ "Bayer Annual Report 2018". www.annualreport2018.bayer.com.
  57. ↑ "Bayer Annual Report 2017" (PDF).
  58. ↑ "Bayer Annual Report 2016" (PDF).
  59. ↑ "Bayer Annual Report 2015" (PDF).
  60. ↑ "Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024" (PDF).
  61. ↑ "Novartis Financial Results Q4 2023" (PDF).
  62. ↑ "Novartis Financial Results Q4 2022" (PDF).
  63. 1 2 Media release 2021 Novartis
  64. ↑ Media release 2019 Novartis
  65. ↑ Media release 2018 Novartis
  66. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  67. ↑ Media release 2016 Novartis
  68. ↑ Media release 2015 Novartis
  69. ↑ "Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025" (PDF).
  70. ↑ "Sanofi Delivers Solid Sales and Business EPS Growth".
  71. ↑ "Sanofi Form 20-F 2022" (PDF).
  72. ↑ "Sanofi Form 20-F 2021" (PDF).
  73. ↑ "Sanofi Form 20-F 2020" (PDF).
  74. ↑ "Sanofi Form 20-F 2019" (PDF).
  75. ↑ "Sanofi Form 20-F 2018" (PDF).
  76. ↑ "Sanofi Form 20-F 2017" (PDF).
  77. ↑ "Sanofi Form 20-F 2016" (PDF).
  78. ↑ "Sanofi Form 20-F 2015" (PDF).
  79. ↑ "Full year and Q4 2023 results" (PDF). AstraZeneca.
  80. ↑ "Full year and Q4 2022 results" (PDF). AstraZeneca.
  81. ↑ "Full year and Q4 2021 results" (PDF). AstraZeneca.
  82. ↑ "Full-year 2020 results" (PDF). AstraZeneca.
  83. ↑ "Full-year and Q4 2019 results" (PDF). AstraZeneca.
  84. ↑ "Full-year and Q4 2018 results" (PDF). AstraZeneca.
  85. ↑ "Full-Year 2017 Results" (PDF). AstraZeneca.
  86. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
  87. ↑ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  88. ↑ "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF).
  89. ↑ "Bristol Myers Squibb Q4 2022 Results" (PDF).
  90. 1 2 "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021" (PDF) (Press release). New York, U.S.: Bristol Myers Squibb. 4 February 2022. Retrieved 2022-09-26.
  91. ↑ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79 [ dead link ]
  92. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  93. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  94. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  95. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  96. ↑ "Abbott Reports Fourth-Quarter and Full-Year 2024 Results".
  97. ↑ "Abbott reports fourth-quarter and full-year 2023 results".
  98. ↑ "Abbott reports fourth-quarter and full-year 2022 results".
  99. ↑ "Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast".
  100. ↑ Abbott 2020 Annual Report (Report). Abbott. 2020.
  101. ↑ "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
  102. ↑ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  103. ↑ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  104. ↑ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  105. ↑ "Abbott Reports Fourth-Quarter 2015 Results".
  106. ↑ "Novo Nordisk Annual Report 2024" (PDF).
  107. ↑ "Novo Nordisk's sales increased by 31% in 2023".
  108. ↑ "Novo Nordisk Financial report for the period 1 January 2022 to 31 December 2022".
  109. 1 2 Novo Nordisk Annual Report 2021 (PDF) (Report). Novo Nordisk. 2021.
  110. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
  111. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
  112. ↑ "News details". www.novonordisk.com. Archived from the original on 2018-02-02. Retrieved 2018-02-01.
  113. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  114. ↑ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  115. ↑ "GSK Full-year and fourth quarter 2024" (PDF).
  116. ↑ "GSK Full-year and Fourth Quarter 2023" (PDF).
  117. ↑ "GSK Full-Year and Fourth Quarter 2022" (PDF).
  118. ↑ "Income statement: Year ended 31 December 2021" (PDF).
  119. ↑ GSK Annual Report 2020 (PDF) (Report). GSK. 2020.
  120. ↑ "Full year and fourth quarter 2019" (PDF) (Press release). London, U.K.: GSK. 5 February 2020. Retrieved 2022-09-26.
  121. ↑ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  122. ↑ "Full year and fourth quarter 2017" (PDF) (Press release). London, U.K.: GSK. 7 February 2018. Retrieved 2022-09-26.
  123. ↑ GSK Annual Report 2016 (PDF) (Report). GSK. 2016.
  124. ↑ GSK Annual Report 2015 (PDF) (Report). GSK. 2015.
  125. ↑ "Shanghai Pharmaceuticals 2023 Annual Report" (PDF).
  126. ↑ "Shanghai Pharmaceuticals 2022 Annual Results Announcement" (PDF).
  127. 1 2 3 4 5 2021 Annual Results Announcement (PDF) (Report). Shanghai Pharmaceuticals.
  128. 1 2 2017 Annual Report (PDF) (Report). Shanghai Pharmaceuticals.
  129. ↑ "Lilly Reports Strong Fourth-Quarter 2023 Financial Results".
  130. ↑ "Lilly Reports Fourth-Quarter 2022 Financial Results".
  131. ↑ "Lilly 2021 Business Results". Lilly.
  132. ↑ "Lilly 2020 Business Results". Lilly.
  133. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition".
  134. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  135. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  136. ↑ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  137. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  138. ↑ "Takeda 2024 Annual Integrated Report" (PDF).
  139. ↑ "Takeda quarterly financial report for the year ended March 31, 2023" (PDF).
  140. ↑ "Takeda quarterly financial report" (PDF). Retrieved June 30, 2022.
  141. ↑ Takeda Quarterly Financial Report (PDF) (Report). Takeda. 31 March 2021.
  142. ↑ "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
  143. ↑ "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
  144. ↑ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  145. ↑ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).
  146. ↑ "Amgen Reports Fourth Quarter and Full Year 2024 Financial Results".
  147. ↑ "Amgen Reports Fourth Quarter and Full Year 2023 Financial Results".
  148. ↑ "Amgen Reports Fourth Quarter and Full Year 2022 Financial Results".
  149. ↑ Amgen Reports Fourth Quarter and Full Year 2021: Financial Results (Report). Amgen. 7 February 2022.
  150. ↑ "2020 Letter to Shareholders". Amgen.
  151. ↑ "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
  152. ↑ "Amgen - Investors - Press Release". investors.amgen.com.
  153. ↑ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  154. ↑ Amgen - Investors - Press Release
  155. ↑ Amgen - Investors - Press Release [ dead link ]
  156. ↑ "Boehringer Ingelheim Financial Highlights 2023".
  157. ↑ "Boehringer Ingelheim Financial Report 2022" (PDF).
  158. ↑ "Boehringer Ingelheim Summary Report 2021" (PDF).
  159. ↑ "Boehringer Ingelheim Annual Report 2020" (PDF).
  160. ↑ "Boehringer Ingelheim Annual Report 2019" (PDF).
  161. ↑ "Boehringer Ingelheim Annual Report 2018" (PDF).
  162. 1 2 3 "Boehringer Ingelheim Annual Report 2017" (PDF).
  163. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results".
  164. 1 2 "Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results" (PDF).
  165. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results" (PDF).
  166. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results".
  167. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  168. 1 2 3 "Investor Overview". Gilead Sciences.
  169. ↑ "Siemens Healthineers closes fiscal year with strong fourth quarter" (PDF).
  170. ↑ "Siemens Healthineers Annual Report 2022" (PDF).
  171. 1 2 Siemens Healthineers Annual Report 2021 (PDF) (Report). Siemens Healthineers. 2021.
  172. ↑ Siemens Healthineers Annual Report 2019 (PDF) (Report). Siemens Healthineers. 2019.
  173. ↑ Siemens Healthineers Annual Report 2018 (PDF) (Report). Siemens Healthineers. 2018.
  174. 1 2 3 Combined Financial Statements for the fiscal years ended September 30, 2017, 2016 and 2015 (PDF) (Report). Siemens Healthineers. 2018.
  175. ↑ "Merck Group Annual Report 2023" (PDF).
  176. ↑ "Merck Group Annual Report 2022" (PDF).
  177. ↑ Merck Annual Report 2021 (PDF) (Report). Merck. 2021.
  178. ↑ Merck Annual Report 2020 (PDF) (Report). Merck. 2020.
  179. ↑ Merck Annual Report 2019 (PDF) (Report). Merck. 2019.
  180. ↑ "Merck Group Annual Report 2018" (PDF).
  181. ↑ "Merck Group Annual Report 2017" (PDF).
  182. ↑ "Merck Group Annual Report 2016" (PDF).
  183. ↑ "Merck Group Annual Report 2015" (PDF).
  184. ↑ "Jointown Pharmaceutical Group Annual Report 2023" (PDF).
  185. ↑ "Google Finance: Jointown Pharmaceutical Group Co Ltd".
  186. ↑ CSR Report 2021 (PDF) (Report). Jointown Pharmaceutical Group.
  187. ↑ CSR Report 2020 (PDF) (Report). Jointown Pharmaceutical Group.
  188. ↑ CSR Report 2019 (PDF) (Report). Jointown Pharmaceutical Group.
  189. ↑ CSR Report 2018 (PDF) (Report). Jointown Pharmaceutical Group.
  190. ↑ CSR Report 2017 (PDF) (Report). Jointown Pharmaceutical Group.
  191. ↑ CSR Report 2016 (PDF) (Report). Jointown Pharmaceutical Group.
  192. ↑ CSR Report 2015 (PDF) (Report). Jointown Pharmaceutical Group.
  193. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results".
  194. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results".
  195. ↑ "GE fourth quarter & full year 2021 performance: Financial results & company highlights" (PDF). GE.
  196. ↑ GE 2020 Annual Report (PDF) (Report). GE. 2020.
  197. 1 2 3 4 5 "General Electric Healthcare segment revenue 2008-2020".
  198. ↑ "Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth".
  199. ↑ "Teva Reports Growth in Fourth Quarter and Full Year 2023".
  200. ↑ "Teva Reports Fourth Quarter and Full Year 2022 Financial Results".
  201. ↑ "Teva Reports Fourth Quarter and Full Year 2021 Financial Results" (PDF). Tel Aviv: Teva. 9 February 2022. Retrieved 2022-09-26.
  202. ↑ TEVA
  203. ↑ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  204. ↑ TEVA
  205. ↑ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  206. ↑ "Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Archived from the original on 2018-02-03. Retrieved 2018-02-08.
  207. ↑ "Teva Reports Full Year 2015 and Fourth Quarter Financial Results". Archived from the original on 2018-09-15. Retrieved 2018-02-08.
  208. 1 2 "Kenvue Reports Full Year and Fourth Quarter 2023 Results".
  209. ↑ "Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results".
  210. 1 2 "Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance".
  211. ↑ "Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results".
  212. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2023 Results".
  213. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2022 Results".
  214. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2021 Results".
  215. 1 2 Statements of Income (Unaudited) Baxter International
  216. 1 2 Statements of Income (Unaudited) Baxter International
  217. ↑ Statements of Income (Unaudited) Baxter International
  218. ↑ Statements of Income (Unaudited) Baxter International
  219. ↑ "Haleon 2023 Full Year Results" (PDF).
  220. ↑ "Haleon 2022 Full Year Results" (PDF).
  221. ↑ "Haleon Prospetus" (PDF).
  222. ↑ "Integrated Report 2024" (PDF). Otsuka Holdings.
  223. ↑ "Consolidated Financial Results for the Fiscal Year Ended December 31, 2022" (PDF). Otsuka Holdings.
  224. 1 2 3 4 5 6 7 "Otsuka Integrated Report 2021" (PDF).
  225. ↑ "Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results".
  226. ↑ "Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results".
  227. ↑ "Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results".
  228. 1 2 Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results (Report). Regeneron. 4 February 2022.
  229. 1 2 3 "Regeneron Form 10-K 2019".
  230. ↑ "Regeneron Form 10-K 2016".
  231. ↑ "Regeneron Form 10-K 2015".
  232. ↑ "Financial Results of Astellas for Fiscal Year 2023" (PDF).
  233. ↑ "Financial Results of Astellas for Fiscal Year 2022" (PDF).
  234. ↑ "Financial Results of Astellas for Fiscal Year 2021" (PDF).
  235. 1 2 For the Year Ended March 31, 2021 Annual Report 2021 (PDF) (Report). Astellas. 31 March 2020.
  236. ↑ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.